Literature DB >> 2784842

Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X).

V Broadbent1, J Pritchard, E Yeomans.   

Abstract

Ten children with Langerhans cell histiocytosis (histiocytosis X) either resistant to or intolerant of corticosteroids received etoposide (VP16). Nine responded. In one instance, partial diabetes insipidus was temporarily reversed. There was no major toxicity. Etoposide should be seriously considered as therapy for patients with LCH in whom the toxicity/benefit ratio of steroid therapy is unacceptably high.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784842     DOI: 10.1002/mpo.2950170205

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  6 in total

1.  Clinical and radiographic response of Langerhans' cell histiocytosis with chemotherapy.

Authors:  J Sánchez de Toledo; F Moraga; A F Teijeiro; R Hidalgo; P Pérez; J C Carreño
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

Review 2.  Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.

Authors:  Milen Minkov
Journal:  Paediatr Drugs       Date:  2011-04-01       Impact factor: 3.022

3.  Langerhans cell histiocytosis--a 31 year review.

Authors:  P Leavey; M Varughese; F Breatnach; A O'Meara
Journal:  Ir J Med Sci       Date:  1991-09       Impact factor: 1.568

Review 4.  Treatment of Langerhans cell histiocytosis--evolution and current approaches.

Authors:  S Ladisch; H Gadner
Journal:  Br J Cancer Suppl       Date:  1994-09

5.  Multisystem Langerhans cell histiocytosis in adult.

Authors:  Anubhav Garg; Pramod Kumar
Journal:  Indian J Dermatol       Date:  2012-01       Impact factor: 1.494

6.  Diagnosis and treatment of Langerhans Cell Histiocytosis with bone lesion in pediatric patient: A case report.

Authors:  Achmad Fauzi Kamal; Andi Praja Wira Yudha Luthfi
Journal:  Ann Med Surg (Lond)       Date:  2019-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.